OneMedNet Corporation Expands Cardiovascular Data Network
OneMedNet Corporation (Nasdaq:ONMD), a recognized leader in AI-driven Real-World Data (RWD), has recently announced a remarkable expansion of its Cardiovascular network. This strategic move entails the addition of 85 new cardiovascular centers and data sources, firmly positioning OneMedNet as one of the largest providers of comprehensive cardiovascular data worldwide.
Understanding Cardiovascular Diseases
Cardiovascular diseases (CVDs) are a pressing global health challenge, emerging as the leading cause of mortality, claiming nearly 19.8 million lives per year. The financial implications are significant, with CVD resulting in an estimated $320 billion in direct healthcare costs annually in the United States alone, and over $1 trillion on a global scale when considering lost productivity.
Meeting Healthcare Needs with Enhanced Data
Given the substantial health and economic burdens of CVD, OneMedNet's enhanced multimodal cardiovascular data network emerges as a vital resource for the pharmaceutical and insurance sectors. By providing real-time access to extensive data, the company enables better insights into disease progression and treatment efficacy, thus fostering more efficient research and development processes. This approach accelerates the creation of innovative therapeutics that can significantly improve patient outcomes.
The Expanded Network's Impact
This expansion is pivotal for OneMedNet, as it enhances the delivery of de-identified cardiovascular imaging and diagnostic reports to life sciences companies, AI developers, and medical device manufacturers. The continual updating of this data ensures that stakeholders benefit from the latest clinical advancements, facilitating informed decision-making and strategic planning.
Innovation Through Collaboration
The integration of newly added sites into OneMedNet's ecosystem solidifies its reputation as the premier provider of high-quality, regulatory-grade cardiovascular RWD. This commitment fuels innovation within the industry while supporting the generation of clinical evidence necessary for improving patient care. With a robust network, the company is set to redefine how data is utilized in the healthcare sector.
"We are dedicated to combining advanced data types—such as de-identified cardiovascular imaging and structured reports—across our vast network. This will equip the industry with the real-world clinical insights it demands, thus accelerating innovation in diagnostics, therapeutics, and AI model development," said Aaron Green, President and CEO of OneMedNet.
About OneMedNet Corporation
OneMedNet is at the forefront of transforming Real-World Data (RWD) through its innovative iRWD™ platform, which taps into a network of more than 1,750 healthcare sites. The company’s offerings include a wide range of data types, from de-identified medical imaging to electronic health records, designed to catalyst breakthroughs for pharmaceutical developers, device manufacturers, and AI innovators. This repository not only spans various fields like oncology and cardiology but also offers precision insights that redefine patient care and bolster healthcare advancements.
Expanding into Diverse Industries
Beyond its primary focus on healthcare, OneMedNet is extending its proprietary AI capabilities into sectors like finance, retail, and telecommunications. By anonymizing sensitive data, the company enables rigorous testing and innovation while ensuring secure data sharing without compromising personal information.
Frequently Asked Questions
What is the main goal of OneMedNet's expansion?
The main goal is to broaden its Cardiovascular data network, providing extensive real-world data to enhance R&D in pharmaceuticals and improve patient outcomes.
How does cardiovascular disease impact the economy?
CVD costs the U.S. approximately $320 billion yearly in healthcare, with global losses exceeding $1 trillion due to lost productivity.
What unique data does OneMedNet offer?
OneMedNet offers a comprehensive range of de-identified cardiovascular data, including imaging, diagnostic reports, and ECG data, which are regularly updated.
Who stands to benefit from OneMedNet's enhanced network?
Pharmaceutical companies, insurance providers, life sciences organizations, and AI developers will all benefit from improved access to valuable cardiovascular data.
In which sectors is OneMedNet expanding its AI capabilities?
The company is also targeting industries like finance, retail, and telecom, creating new opportunities by anonymizing and securely sharing data.
